SC 13D/A

AMENDMENT NO. 1 TO SCHEDULE 13D

Company: China SXT Pharmaceuticals, Inc.
Filed: January 30, 2023
Accession Number: 0001213900-23-005997

View Document ↗ View on SEC.gov ↗